| Table 1. Effect of Liraglutide on Reproductive Outcomes and Recommendations | ||
| Parameter / Outcome | Effect of Liraglutide | Notes / Comments |
|---|---|---|
| Spontaneous ovulatory cycles | Increased | Observed mainly in women with PCOS |
| Total gonadotropin dose in IVF cycles | Reduced | Some studies report lower gonadotropin requirement |
| Live birth rate | No consistent improvement | No significant change demonstrated |
| Use during active conception attempts | Contraindicated | Lack of fetal safety data |
| Preconception recommendations | Discontinue >=4 weeks before conception; use effective contraception | Aligns with international safety guidelines |